Drug Patents owned by Serenity Pharms Llc

1. List of Noctiva drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7579321 SERENITY PHARMS LLC Pharmaceutical compositions including low dosages of desmopressin
May, 2023

(2 months from now)

US7405203 SERENITY PHARMS LLC Pharmaceutical compositions including low dosages of desmopressin
May, 2023

(2 months from now)

US7799761 SERENITY PHARMS LLC Pharmaceutical compositions including low dosages of desmopressin
Sep, 2024

(1 year, 7 months from now)

US9539302 SERENITY PHARMS LLC Safe desmopressin administration
Jun, 2030

(7 years from now)

US11419914 SERENITY PHARMS LLC Safe desmopressin administration
Jun, 2030

(7 years from now)

Drugs and Companies using DESMOPRESSIN ACETATE ingredient

Market Authorisation Date: 03 March, 2017

Treatment: A method of treating nocturia due to nocturnal polyuria in adults; Treatment of nocturia due to nocturnal polyuria in adults who awaken at least 2 times per night to void by inducing an antidiuretic effect by intranasally administering a plume of droplets comprising a dose of about 0.05-5 mcg desmopressin

Dosage: SPRAY, METERED;NASAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in